IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Ulrich Eder

USPTO Granted Patents = 34

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 153(Granted Patents)


Company Filing History:

goldMedal32 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal2 out of 41 
 
A/s Ferrosan
 patents
bronzeMedal1 out of 1 
 
Scherling Ag
 patent
4. 1 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
where one patent can have more than one assignee

Years Active: 1976-1991

Loading Chart...
34 patents (USPTO):Explore Patents
1. 5010077 - .beta.-carbolin-3-carboxylic acid derivatives useful for treating (1991-04-23),
2. 4826852 - Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful (1989-05-02),
3. 4601746 - Substituted sulfonylurea, processes for the production of these (1986-07-22),
4. 4596808 - Pharmacologically active 3-substituted beta-carbolines useful as (1986-06-24),
5. 4591650 - Hexanor-brassinolid-22-ethers (1986-05-27),
6. 4435403 - Pharmacologically active 3-substituted beta-carbolines (1984-03-06),
7. 4379790 - (Erolinyl)-N,N-diethylurea derivatives, and their preparation and use (1983-04-12),
8. 4371536 - .beta.-Carbolin-3-carboxylic acid derivatives (1983-02-01),
9. 4333928 - 16 .alpha.-Alkyl steroids, their preparation, and pharmaceutical (1982-06-08),
10. 4298538 - 16-Dimethylaminomethylene-3-methoxy-1,3,5-(10)-estratrien-17-one, a (1981-11-03),
11. 4202991 - Novel bicycloalkane derivatives and the production thereof (1980-05-13),
12. 4178381 - C-homoestratrienes (1979-12-11),
13. 4170518 - Microbiological conversion of sterol derivatives to 5-androsten-17-one (1979-10-09),
14. 4155923 - Process for the preparation of 17.beta.-hydroxy-20-alkoxypregnane-21-oic (1979-05-22),
15. 4108871 - Novel benzopyran derivatives (1978-08-22),

Title: The Innovative Mind of Ulrich Eder

Introduction

Ulrich Eder, based in Berlin, Germany, is a prolific inventor known for his significant contributions to the field of chemical compounds. With a remarkable portfolio of 34 patents, Eder has focused much of his research on developing novel derivatives and compounds that hold therapeutic potential.

Latest Patents

Among his latest patents, Eder has introduced innovative compounds such as beta-carbolin-3-carboxylic acid derivatives, which prove useful in treating various medical conditions. One of these derivatives is characterized by the formula where X can be oxygen, sulfur, or a nitrogen group with varying alkyl and cycloalkyl side chains. Additionally, he has worked on novel ergolinyl compounds that are nitrogen-substituted in the 8-position, which also encompass physiologically compatible salts, showcasing his dedication to exploring diverse chemical structures for potential therapeutic applications.

Career Highlights

Eder’s career includes significant tenure at renowned companies such as Schering Aktiengesellschaft and A/S Ferrosan. His work at these institutions has advanced the research and application of chemical compounds in medicinal chemistry, making substantial contributions to the pharmaceutical industry.

Collaborations

Throughout his career, Eder has collaborated with notable colleagues, including Rudolf Wiechert and Gerhard Sauer. These collaborations have undoubtedly enriched his research endeavors and contributed to the successful development and patenting of innovative compounds.

Conclusion

Ulrich Eder’s contributions as an inventor underline the impact of innovation on medicine and chemistry. His extensive patent portfolio reflects a deep commitment to research and development, leading to significant advancements in therapeutic compounds. As he continues to innovate, his work remains influential in the pursuit of effective treatments and improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…